Dr. Reddy's Laboratories, Inc. is voluntarily recalling approximately 150,040 bottles of IBU Ibuprofen Tablets (ibuprofen) in 400 mg, 600 mg, and 800 mg strengths. The recall was initiated because the tablets failed testing for impurities, showing levels of an unknown degradation product that exceed safety specifications. The affected products include 100-count and 500-count bottles distributed nationwide in the USA and Puerto Rico.
The drug failed to meet specification limits for an unknown impurity, which could potentially affect the stability or safety of the medication over time. No incidents or adverse reactions have been reported to date for these products.
You have 2 options:
100 Tablets per bottle (NDC 55111-684-01) and 500 Tablets per bottle (NDC 55111-684-05).
100 Tablets per bottle (NDC 55111-683-01) and 500 Tablets per bottle (NDC 5511-683-05).
100 Tablets per bottle (NDC 55111-682-01) and 500 Tablets per bottle (NDC 55111-682-05).
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.